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Abstract
Advances in food transformation have dramatically increased the diversity of products on the market and, consequently, exposed consu-
mers to a complex spectrum of bioactive nutrients whose potential risks and benefits have mostly not been confidently demonstrated.
Therefore, tools are needed to efficiently screen products for selected physiological properties before they enter the market. NutriChip
is an interdisciplinary modular project funded by the Swiss programme Nano-Tera, which groups scientists from several areas of research
with the aim of developing analytical strategies that will enable functional screening of foods. The project focuses on postprandial inflam-
matory stress, which potentially contributes to the development of chronic inflammatory diseases. The first module of the NutriChip project
is composed of three in vitro biochemical steps that mimic the digestion process, intestinal absorption, and subsequent modulation of
immune cells by the bioavailable nutrients. The second module is a miniaturised form of the first module (gut-on-a-chip) that integrates
a microfluidic-based cell co-culture system and super-resolution imaging technologies to provide a physiologically relevant fluid flow
environment and allows sensitive real-time analysis of the products screened in vitro. The third module aims at validating the in vitro
screening model by assessing the nutritional properties of selected food products in humans. Because of the immunomodulatory proper-
ties of milk as well as its amenability to technological transformation, dairy products have been selected as model foods. The NutriChip
project reflects the opening of food and nutrition sciences to state-of-the-art technologies, a key step in the translation of transdisciplinary
knowledge into nutritional advice.
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Current trends in human nutrition
Dynamic definition of health
In 1946, the WHO defined health as ‘a state of complete physi-
cal, mental and social well-being and not merely the absence of
disease or infirmity’(1). This definition contains a static compo-
nent that no longer suits current knowledge in the biomedical
sciences. The conference ‘Is health a state or ability? Towards
a dynamic concept of health’ has revised this definition and
proposed a more dynamic approach by defining health as ‘the
ability to adapt and to self manage’(2). In this context, the
increased incidence of chronic metabolic diseases paralleling
the ageing of the human organism may be due to a loss in the
metabolic plasticity of the organism, i.e. its ability to respond
adequately in a timely and quantitative manner to external chal-
lenges(3). The metabolic nature of food indicates that nutrition
could positively or negatively modulate metabolic plasticity
and consequently the development of chronic diseases.
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Food is more than a confounding factor
That nutrition is crucial to growth, development, function and
the maintenance of health is obvious. In wealthy societies, the
prevention and treatment of disease is most obviously associ-
ated with the widespread use of pharmaceuticals rather than
dietary modification. There are many more scientific publi-
cations on pharmaceuticals than on food. Why is that so?
Beyond obvious economical arguments, a comparison of the
chemical and biological properties of food and drugs explains
the imbalance in research activities: drugs are mostly single
chemical entities possessing targeted pharmacological activity
and being adsorbed in a supervised manner. Food, on the
other hand, is composed of thousands of uncharacterised
chemical compounds that are ingested unsupervised(4). Thus
it seems that scientists may have been so far lacking the
tools to characterise the interaction of food with the human
organism as efficiently as in the case of drugs.
Towards nutritional systems biology
The application of functional genomics to the fields of food
and nutrition sciences is about to surmount this hurdle. The
molecular fate of nutrients in ingested food (composition,
digestion, intestinal transport, metabolic activation, excretion)
can now be monitored in humans with a precision, sensitivity
and functional understanding that was previously not poss-
ible. Human tissues and fluids can be investigated for their
epigenetic, genetic, transcriptomic, proteomic and metabo-
lomic profiles and complement classical analyses to obtain
holistic information on the molecular processes taking place
as the response of the organism to the ingestion of food(5).
Studies that combine these analytical levels are still rare(6)
but they are precursors of a nutritional systems biology,
which will move nutritional science one step closer to an
objective understanding of the effects of food on human
physiology, in particular on the maintenance of health.
Postprandial stress: a surrogate of metabolic plasticity?
As the analytical tools are available, the challenge is now to
translate the concept of metabolic plasticity into parameters
that are measurable and nutritionally relevant. The cellular
metabolism of nutrients, culminating in the synthesis of the
biochemical energy embodied in ATP, produces side effects
that include the mitochondrial production of reactive oxygen
species (oxidative stress), the synthesis of misfolded proteins
(endoplasmic reticulum stress) and the activation of defence
mechanisms by immune cells (inflammatory stress). These
effects accumulate at the level of the organism to produce a
phenomenon named postprandial stress(7). Under normal
conditions, postprandial stress is of low magnitude and transi-
ent in nature so that it disappears within a few hours post-
ingestion. An unhealthy diet, permanent snacking and/or a
diseased organism may, however, increase the magnitude of
postprandial stress and/or delay its recovery so that fasting
baseline values for markers of postprandial stress may
increase over time and contribute to the development of
chronic metabolic diseases(7). This concept has already been
demonstrated for glucose in human blood as the glycaemic
index, a measure of the postprandial glucose response,
emerges as a potentially important determinant of the risk
of cardiovascular diseases(8). We propose that postprandial
stress can be used as an indicator of metabolic plasticity
and, consequently, of health.
Blood as a source of biomarkers
Biomarkers in blood can provide specific information on the
health status of organs, such as the heart, liver or kidney.
The diagnostic strength of clinical chemistry is due to the
ability of blood to serve as a sentinel of the body carrying
molecular information between organs(9). As clinical chemistry
informs physicians about the ability of patients to respond to
drugs, the same strategy should be used by nutritionists to
monitor the quality of the interaction between consumers
and food products. The assessment of metabolic and immuno-
modulatory biomarkers (insulin, glucose, TAG, cholesterol,
hormones, cytokines, etc.) already belongs for decades to
the arsenal of tools used by nutritional scientists. This arsenal
is, however, in the process of being dramatically augmented
with the advent of nutrigenomics(5). Blood, as a connective
fluid tissue, is very appropriate for the monitoring of bio-
markers indicating postprandial stress in order to assess the
impact of food on metabolic plasticity.
Probing the impact of nutrition on postprandial systemic
inflammation in humans
High-fat meals are associated with postprandial systemic
inflammation
Inflammation is a major component of metabolic diseases.
Subjects ingesting high-fat meals experience a postprandial
systemic rise in pro-inflammatory cytokines, the level of
these cytokines being higher in obese than in lean subjects(10).
A repetition of postprandial inflammatory stress over pro-
longed periods of time may significantly contribute to the
development of chronic inflammation. In that context, epide-
miology has established a positive correlation between a diet-
ary regimen rich in trans-fatty acids and fasting markers of
systemic inflammation(11). Clear evidence for a relationship
between the consumption of high-fat meals and chronic
low-grade inflammation has, however, not been demon-
strated, taking into account the fact that carbohydrates may
also contribute to this phenomenon(12). The inflammatory
stress imposed by inadequate or inappropriate diets may con-
tribute negatively to the maintenance of health by reducing
the metabolic plasticity of the organism. A quantitative anal-
ysis of the postprandial kinetics of inflammatory biomarkers
in the blood of human subjects thus provides information
on the quality of the interaction between specific foods
and the organism. This proposition forms the conceptual
basis for the biological modules of the present NutriChip
project (Fig. 1).
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Anti-inflammatory properties for dairy products?
Several food products, including orange juice(13) and
tomato(14), have been demonstrated to reduce the postpran-
dial inflammatory response to high-fat meals. Dairy products
may also have anti-inflammatory properties in human adults.
Lower levels of fasting pro-inflammatory cytokines have
indeed been documented in epidemiological(15) and interven-
tion(16) studies in human adults consuming dairy products.
Decreased postprandial levels of pro-inflammatory cytokines
after the consumption of dairy products have also been
reported(17). We have investigated the postprandial kinetic
response of healthy human subjects to the ingestion of dairy
products by measuring the genome-wide expression of
genes in the subjects’ blood cells. This analysis revealed a
common postprandial kinetic pattern for the expression of
inflammatory genes, thus illustrating the tight link between
nutrition and the immune system(18).
Milk is a unique food; its immunomodulatory properties
result from two hundred million years of evolution of the
mammary gland(19). Milk can also be transformed technologi-
cally in an almost infinite number of ways. In particular, the
fermentation of milk by lactic acid bacteria clearly adds
to its immunomodulatory potential(20), even more since
recent analytical breakthroughs highlight the importance of
the gut microbiota on human metabolism(21). Milk thus
appears to be a strategic vector to deliver immunomodulatory
nutrients to the human organism in order to improve its
metabolic health.
Comparative analysis of postprandial inflammatory stress
in humans
High-fat meals can be used as ‘positive controls’ eliciting the
postprandial production of inflammatory cytokines in
humans, against which other products can be compared. In
order to identify suitable conditions for carrying out such com-
parative studies, the relationship between the energy dose of
the selected high-fat meal and the postprandial production of
inflammatory cytokines should be investigated. High-energy
doses may induce a significant inflammatory response and
consequently allow the identification of statistically significant
changes even with a relatively small number of subjects. On
the other hand, low-energy doses may be nutritionally more
realistic and provide more flexibility in designing interventions
that evaluate the ability of co-ingested food products to inhibit
the postprandial inflammation induced by a high-fat meal. The
present NutriChip project measures the postprandial inflam-
matory stress of subjects having ingested three different
energy doses of a fatty meal. Pro-inflammatory cytokines,
such as IL-6, are measured as markers for inflammation.
Development of dairy products
Biomarkers
Nutritional studies In vitro screening of digestion, intestinal transport and bioactivation
- Technological transformation
- Microbiological transformation
- Intestinal absorption (nutrikinetics)
- Metabolism, inflamation, endotoxinaemia
- Functional genomics (transcriptomics, metabolomics)
- Lean and obese subjects
- Energy dose–response
- Postprandial metabolism
Digestion
Transwell (macroscale) NutriChip (microscale)
Intestinal transport and bioactivation
Selection and characterisation of dairy products
Fig. 1. Overview of the biological modules of the NutriChip project.
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The pro-inflammatory environment is exacerbated in
humans with metabolic diseases(10). The NutriChip project
thus compares the postprandial stress of lean healthy subjects
to subjects with metabolic diseases. As the biological pro-
cesses regulating inflammation and the metabolism of macro-
nutrients are interconnected(22), measuring the postprandial
metabolic response (insulin, glucose, TAG, lipoproteins) in
addition to the inflammatory markers should provide further
insight into the impact of food on the organism.
In addition to the discrete set of metabolic and immune-
modulatory parameters, the blood cell transcriptome and the
serum metabolome of the lean and obese subjects are
measured. A comparative analysis of the fasting and postpran-
dial samples then allows the identification of biomarkers
modulated by nutrition that may have an impact on the devel-
opment of metabolic diseases.
Screening food products in an in vitro model of digestion
In vitro screening strategy
Despite their complexity, human intervention studies are
clearly the ‘gold standard’ in nutritional science(23). Their limi-
tations are logistical in nature, as the resources necessary to
screen a large number of products for specific properties are
prohibitive. Furthermore, the use of human subjects as a
screening tool to test products that are not bioactive or even
unsafe is unethical even if the trials involve a low grade of
invasiveness by limiting analyses to blood samples. In vitro
models are thus needed for the efficient screening of bioactive
food products. In the NutriChip project, a panel of dairy
products is digested in vitro, the digested nutrients are trans-
ported through an intestinal cell monolayer, and the ability
of the transported nutrients to modulate the inflammatory
activity of immune cells is finally measured. The immuno-
modulatory properties of these products are compared to
those of the high-fat meal and the most active dairy products
are tested in human intervention trials.
Characterising the molecular composition of the test
products
If one wants to follow the fate of the nutrients present in food
during digestion, intestinal transport and metabolic activation,
the composition of the undigested food should first be charac-
terised at the molecular level. Recent developments in the
fields of proteomics/peptidomics(24) and metabolomics/lipido-
mics(25) now allow food scientists to go significantly beyond
the macronutrient composition of food, thus opening the
path to the identification of specific bioactive molecules in
food products. As the delivery of high-density data increases,
sharing this information by creating interactive data banks that
can be used by the scientific community has the potential
to boost the efficacy of food and nutrition research. In the
context of the NutriChip project, several hundred milk and
bacterial proteins have been separated by two-dimensional
PAGE and identified by liquid chromatography coupled to
MS (LC–MS) in a variety of dairy products. The reference
maps will be made freely available in the form of an inter-
active online platform, the Dairy Protein Atlas (R. Portmann,
private communication).
In vitro digestion
In vitro models that mimic human digestion are the subject of
intense research(26). The European COST Action FA1005
(Improving health properties of food by sharing our know-
ledge on the digestive process) was initiated in 2011 and
aims to harmonise research by defining a reference model
for in vitro digestion. Most models are composed of three
steps that represent digestion along the gastrointestinal tract.
Appropriate buffer composition, identity and concentration
of digestive enzymes, pH, and digestion times are selected
accordingly. The first step mimics digestion by saliva in the
mouth. The second step mimics gastric digestion in the pre-
sence of pancreatic juice. The third step models intestinal
digestion in the presence of bile salts. The most advanced
models introduce dynamic features such as mastication, peri-
staltic movements or the controlled secretion of digestive
juices. Whereas dynamic models are closer to human physi-
ology, the less elaborate static models are still widely used
in most research laboratories(26).
The NutriChip project has validated a static three-step
model for the specific digestion of dairy products using
pasteurised whole milk as a standard(27). Interestingly, a com-
parison of the amino acids released from milk proteins during
the course of the in vitro digestion revealed that the fraction of
essential amino acids released by digestion was significantly
higher than the total fraction of these amino acids present in
the entire pool of milk proteins. This observation suggests
that the digestive system has evolved in a way that allows
an efficient extraction of the essential amino acids present in
food, in particular in milk.
Transport through confluent intestinal cells
In analogy to pharmacokinetics, the concept of nutrikinetics
becomes more and more important in nutrition science. The
absorption of nutrients through intestinal cells significantly
contributes to their bioavailability. In vitro, the intestinal trans-
port of nutrients is most often measured with the confluent
layers of intestinal cell lines(28), although intestinal tissues
isolated from animals are also used(29). Proteomics and meta-
bolomics will dramatically increase our knowledge of the
intestinal transport of nutrients. For example, while the trans-
port of amino acids, dipeptides and tripeptides is well charac-
terised, the transport of larger peptides, even of intact
proteins, remains poorly characterised. In particular, the popu-
lation and fraction of large peptides being transported through
the gut, the mechanisms mediating this transport and even its
biological significance are current research challenges(30).
High-density (‘omics’) data gained from in vitro experiments
will allow the identification of bioavailable nutrients, which
will then be specifically traced in humans. Such data will con-
tribute to the identification of functional food components as
well as to a better understanding of the mechanisms mediating
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oral tolerance(31). A high-density analytical strategy (metabolo-
mics, peptidomics) can thus be applied to identify the metab-
olites transported through a confluent layer of Caco-2 cells.
The identified dairy nutrients can then be investigated for
their presence in the postprandial sera of human subjects par-
ticipating in intervention studies.
Inflammatory action of nutrients on immune cells
Once transported and metabolised by the intestinal cellular
barrier, the primary fate of nutrients is to interact with recep-
tors on their target organs and cells. Immune cells are obvious
cellular targets to demonstrate the pro- or anti-inflammatory
potential of the translocated molecules. The design of the
immunomodulatory in vitro system depends on the mechan-
ism inducing the postprandial activation of inflammatory cyto-
kines in response to a high-fat meal. Several mechanisms can
be put forward to account for this activation effect(7,12,13,32–34):
(i) long-chain fatty acids activate the Toll-like receptor path-
way of immune cells; (ii) fat promotes the translocation of
bacterial endotoxin from the gut into the circulation by
increasing paracellular intestinal permeability; (iii) the fatty
acid particles undergoing intestinal transcytosis are intracellu-
lar cargos for bacterial endotoxin; (iv) the metabolism of the
energy-dense fat macronutrients induces the production of a
non-specific cellular stress response. The NutriChip project
uses a co-culture Transwell system composed of a confluent
layer of Caco-2 cells, which allows the application of in
vitro digested food on its apical side, and a basolateral culture
of a monocytic cell line differentiated to macrophages, which
will react to the presence of pro-inflammatory molecules in
the basolateral media by producing inflammatory cytokines,
such as IL-6. The Transwell system allows a wide range of
variations in the experimental set-up that will enable the
different inflammatory models proposed here to be tested.
The NutriChip
The Transwell co-culture system suffers from several draw-
backs, in particular its inability to provide a dynamically con-
trolled flow of cell nutrients and stimuli to the in vitro
intestinal model, the long growth times needed for the intesti-
nal cells to differentiate into functional enterocytes and to
reach confluence, the high costs of the system (since it
demands relatively large volumes of media to grow the
cells), and an external signal detection system that requires
the manual withdrawing and manipulation of samples. The
NutriChip project takes a micro-engineering strategy to allevi-
ate these hurdles. The NutriChip is a miniaturised replica of
the Transwell system integrated into a micro-system (Fig. 2).
The gut-on-a-chip
Working with a microfluidic chip allows significant reduction
of the liquid volumes of cell culture chambers (down to the
10ml range), when compared to a classical co-culture
system. Therefore, the use of microfluidic devices will lead
to reduced reagent consumption, and obviously reagent-
associated costs can be diminished accordingly. Moreover,
miniaturisation procedures allow the fabrication of many iden-
tical analytical devices on a given microfluidic chip surface,
paving the way for parallel assays and high-throughput ana-
lyses. Microfluidic chips can also be equipped with certain
functionality, at the cost of some technological effort and com-
plexity; for example, miniaturised valves and pumps can be
configured on the chip, which can be easily operated using
Collimating lens
Light source
Optical filter
Optical filter system
Low-noise integrated
photodetector array
High-resolution focus
optical lens system
Digital processing unit
Pri
nte
d c
ircu
it b
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d
NutriChip
Reflective optics
Fig. 2. A schematic representation of the engineering modules of the NutriChip project (adapted from http://www.nano.tera.ch/projects/403.php).
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external pressure control. Such valves also permit to separate
on-chip the two cell types of the co-culture system, which
allows both types of cells to grow independently under
optimum media conditions and permits them to correctly
differentiate. If it is observed that both cell types have reached
the target structure (e.g. formation of a confluent layer for
the epithelial cells and differentiation of the seeded monocytic
cells to macrophages), the two cell reservoirs can be put
in fluidic communication by simply opening an on-chip
valve and the chip can then be exploited for food testing.
The microfluidic chips will be configured with a suitable
microfluidic architecture, i.e. appropriate microchannels for
exposing the cell solutions to culture media, washing buffer,
fluorescent detection labels, functionalised magnetic beads,
etc., which will allow controlled and quantitative testing of
the food quality parameters(35).
Going ‘nano’ and ‘tera’ with the NutriChip
Subjects ingesting high-fat meals have increased postprandial
levels of insulin, glucose, TAG, cholesterol and pro-
inflammatory cytokines released in the blood serum as well
as activation of Toll-like receptors in their immune cells.
The artificial gut-on-a-chip described previously will allow
the quantitative acquisition of terabytes of information related
to the nanoscale metabolic and immunomodulatory bio-
markers. Although electrochemical detection of insulin(36),
glucose(37) and cholesterol(38) has been already demonstrated
in vitro, the first prototype of the NutriChip implements the
direct fluorescent detection of Toll-like receptors on Caco-2
cells as well as of IL-6 in the media. Microfluidic chips are
ideally suited to optical detection methods due to the non-
invasive nature of the optical measurement techniques and
the transparency of the microfluidic fabrication materials
(e.g. glass and polydimethylsiloxane). The fluorescence inten-
sity of light will be acquired with a dedicated complementary
metal oxide semiconductor imager and fluorescent dyes as
labels for the cells’ receptors, while functionalised (anti-IL-6)
magnetic micro-beads will be used for the capturing of the
IL molecules and their quantification with an in situ immuno-
magnetic assay. Special complementary metal oxide semicon-
ductor design will reduce the imager noise while decreasing
the pixel area of sensors. This approach enables an image
quality comparable with that obtained by using charge
coupled device cameras(39). Special image processing and
analysis will increase the quality of the quantification of
metabolites, thanks to more precise target sub-resolution
and generation of synthetic images of fluorescent stained
cells(40). Therefore, the final optical detection system will com-
bine a complementary metal oxide semiconductor imager and
an integrated electronic microchip for the online quantitative
analysis. The combination of the dynamic microfluidic-
based cell co-culture, with prolonged time perfusion-based
exchange of media and reagents, and the imaging system
will offer near-real-time live-cell imaging for continuous
tracking of the variation of immune cell response to perfused
stimuli in a time-lapsed manner.
Limitations and applications of the NutriChip
Keeping in mind the versatility of the immune system,
the limitations of the co-culture system as a model to mimic
human digestion, intestinal transport of nutrients and
immune activation by the absorbed nutrients are obvious.
Care should thus be taken not to uncritically extrapolate the
in vitro data to the in vivo situation. A comparative in vitro
screening of the inflammatory properties of different food
products should, however, reveal quantitative differences
that are likely to be retrieved in vivo in the postprandial
inflammatory response of the subjects having ingested these
products. Thus, the dairy products selected in vitro for a
low inflammatory impact, compared to the high-fat meal,
will have to demonstrate the same relative activity in the
human trial presented here.
The potential of the NutriChip extends beyond the identifi-
cation of food products with a low impact on inflammatory
stress. We are currently adapting the NutriChip to evaluate
the effect of the food matrix on the intestinal transport of Ca
(Ca-NutriChip). A recent report investigating the intestinal
adhesion and metabolic activity of a probiotic bacterium
suggests that guts-on-a-chip have the potential of better
mimicking the in vivo situation than their macroscopic co-
culture counterparts(41). Technologies are also available to
extend the functionality of the NutriChip upwards to include
the three in vitro digestion steps outlined earlier. Finally, in
addition to food science and nutrition, the NutriChip should
find applications in all fields of human biology in which
gastrointestinal phenomena are important, in particular in
medicine, pharmacology and toxicology.
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